Bruker Corporation (NASDAQ:BRKR) Plans Quarterly Dividend of $0.05

Key Points

• Bruker declared a quarterly dividend of $0.05 per share, payable October 7 to shareholders of record on September 21. The dividend implies $0.20 annually and a 0.3% yield.
• The dividend appears well covered, with a current payout ratio of 7.3%; analysts expect earnings of $2.43 per share next year against the projected $0.20 annual dividend.
• Bruker reported quarterly EPS of $0.49, exceeding estimates of $0.38, while revenue rose 5.2% year over year to $838.5 million, below the $853.57 million consensus estimate.

Bruker Corporation (NASDAQ:BRKR - Get Free Report) announced a quarterly dividend on Friday, August 14th. Shareholders of record on Monday, September 21st will be paid a dividend of 0.05 per share by the medical research company on Wednesday, October 7th. This represents a c) dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, September 21st.

Bruker has raised its dividend payment by an average of 0.0%annually over the last three years. Bruker has a dividend payout ratio of 7.3% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Bruker to earn $2.43 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 8.2%.

Bruker Stock Down 2.6%

NASDAQ BRKR opened at $61.39 on Friday. Bruker has a 52 week low of $30.09 and a 52 week high of $65.30. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $9.35 billion, a P/E ratio of -87.70, a price-to-earnings-growth ratio of 1.93 and a beta of 1.26. The stock's 50-day moving average price is $58.17 and its 200-day moving average price is $49.90.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.11. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The company had revenue of $838.50 million during the quarter, compared to the consensus estimate of $853.57 million. During the same period in the previous year, the company posted $0.32 EPS. The firm's revenue was up 5.2% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, equities research analysts predict that Bruker will post 2.12 earnings per share for the current year.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company's product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.